These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10997326)

  • 21. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased peripheral stem cell pool in MDS: an indication of disease progression?
    Vehmeyer K; Haase D; Alves F
    Leuk Res; 2001 Nov; 25(11):955-9. PubMed ID: 11597730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myelodysplastic syndromes: current diagnosis and classification].
    Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
    Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
    Das R; Hayer J; Dey P; Garewal G
    Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis.
    Mihara K; Chowdhury M; Nakaju N; Hidani S; Ihara A; Hyodo H; Yasunaga S; Takihara Y; Kimura A
    Blood; 2006 Jan; 107(1):305-8. PubMed ID: 16160010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
    Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes.
    Torlakovic G; Langholm R; Torlakovic E
    Arch Pathol Lab Med; 2002 Jul; 126(7):823-8. PubMed ID: 12088452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
    Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts.
    Kerndrup G; Pedersen B; Ellegaard J; Hokland P
    Blut; 1986 Jan; 52(1):35-43. PubMed ID: 3455830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
    Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
    J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.